Pharma
Pharma companies are going all in on rare disease treatments
Drugs designed to treat rare diseases now make up half of new drug approvals each year.
Stay updated on Orphan Drugs trends and industry impact. Healthcare Brew provides the latest news and professional analysis on Orphan Drugs's role in Drug Discovery & Development and Pharma.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.